Google+ Facebook Twitter Twitter

Genetic risk for IBD patients

In a retrospective study, investigators found that a combination of rare and common genetic variants in some inflammatory bowel disease (IBD) patients significantly increased their risk of developing clot-causing thromboembolic diseases.

Senior author Dermot P McGovern said: “The genetic signature we identified more than doubled the risk of developing potentially fatal blood clots in approximately one in seven IBD patients.

“While the risk for blood clots in IBD patients could be attributed to episodes of severe inflammation in the gastrointestinal tract that led to surgery, or to a side-effect of some medications, very little was known about the impact of genetics on that risk.”

Researchers used whole-genome sequencing and genotyping to assess 792 IBD patients and then identify patterns associated with the development of venous or arterial thromboembolisms.

Image Credit: Shutterstock

Related Articles

The big question: molecular diagnostics

“Do you think the more we edge towards molecular diagnostics, the higher the likelihood that we will see biomedical science disciplines phased out in the future?”

Lab-on-a-chip for PCR

A new lab-on-a-chip infection test could provide cheaper, faster portable diagnostics, it is claimed.

National Genomic Research Library grows to over 110,000

The National Genomic Research Library (NGRL) now contains one of the richest genomic datasets in the world for both rare disease and cancer research.

NHS to pilot potentially revolutionary blood test

A blood test that may spot more than 50 types of cancer will be piloted by the NHS in a world-leading programme.